Details for Patent: 8,450,375
✉ Email this page to a colleague
Which drugs does patent 8,450,375 protect, and when does it expire?
Patent 8,450,375 protects VALCHLOR and is included in one NDA.
This patent has fifty patent family members in twenty countries.
Summary for Patent: 8,450,375
Title: | Stabilized compositions of volatile alkylating agents and methods of using thereof |
Abstract: | A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier that does not include petrolatum or ethanol does not include petrolatum or ethanol. The method comprises topically applying the composition of a Nitrogen Mustard or a HX salt of the Nitrogen Mustard to the affected skin, wherein the Nitrogen Mustard or the HX salt of the Nitrogen Mustard is in a non-aqueous vehicle or carrier that does not include petrolatum or ethanol, wherein the non-aqueous vehicle or carrier does not include petrolatum or ethanol. |
Inventor(s): | Alonso; Robert (Rye, NH), Crooks; Peter A. (Nicholasville, KY), Pimley; Mark A. (Westchester, PA), Al-Ghananeem; Abeer M. (Lexington, KY) |
Assignee: | Ceptaris Therapeutics, Inc. (Malvern, PA) |
Application Number: | 11/908,531 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,450,375
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,450,375
PCT Information | |||
PCT Filed | March 14, 2006 | PCT Application Number: | PCT/US2006/009060 |
PCT Publication Date: | September 21, 2006 | PCT Publication Number: | WO2006/099385 |
International Family Members for US Patent 8,450,375
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2006223076 | ⤷ Try a Trial | |||
Canada | 2600468 | ⤷ Try a Trial | |||
China | 101175735 | ⤷ Try a Trial | |||
China | 102036557 | ⤷ Try a Trial | |||
China | 107149591 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |